Moreno C, Byrd JC, Hillmen P, et al. Ibrutinib in previously treated chronic lymphocytic leukemia updated efficacy and safety of the RESONATE study with up to four years of follow-up. EHA 2017, abstract S769.
Lebrikizumab en melfalan flufenamide in de sluis geplaatst
dec 2023 | Eczeem, MM